Bengaluru-based biopharmaceutical major Biocon reported a consolidated net profit of Rs 143.8 crore for the third quarter of 2025–26 (Q3FY26), a rise from a low base of Rs 25.1 crore in the same ...
It’s a familiar moment in math class—students are asked to solve a problem, and some jump in confidently while others freeze, unsure where to begin. When students don’t yet have a clear mental model ...
Stat reports that at least 18 brand-name drugs on TrumpRx are available in generic form for cheaper through GoodRx or Cost Plus Drugs. Plus: Democratic Sen. Ron Wyden of Oregon called TrumpRx "nothing ...
Pacira BioSciences trades at distressed levels due to fears of EXPAREL patent erosion, despite strong cash flow and 78% gross margins. EXPAREL's manufacturing complexity and hospital adoption create a ...
President Trump on Thursday unveiled his lower-cost drug platform TrumpRx, touting it as “one of the most transformative health care initiatives of all time.” “This launch represents the largest ...
John Wilkerson is a Washington correspondent for STAT who writes about the politics of health care. He is also the author of the twice-weekly D.C. Diagnosis newsletter. Emory is the data editor at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results